D
Bausch Health Companies Inc. BHC.TO
TSX
Recommendation
Sell
Prev Close
$10.26
Volume
--
Avg Vol (90D)
307,078
Market Cap
$2.63B
Dividend & Yield
--
52-Week Range
$5.45 - $15.43
P/E (TTM)
--
EPS (TTM)
-$0.128
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Excellent
Efficiency Index
Very Weak
Solvency Index
Fair
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Bausch Health Companies (BHC, $7.15) Stochastic Oscillator left the oversold zone on March 07, 2025
3/8/2025 - Tickeron - Stocks
Bausch Health Companies (BHC, $7.15) entered Downtrend as Momentum indicator drops below 0 level on Mar 07, 2025
3/8/2025 - Tickeron - Stocks
Bausch Health Companies Inc. (NYSE:BHC) Given Consensus Recommendation of "Reduce" by Brokerages
3/7/2025 - Ticker Report
Bausch Health Companies Inc. (NYSE:BHC) Given Consensus Rating of "Reduce" by Brokerages
3/7/2025 - MarketBeat
Bausch Health Companies (BHC, $7.17) price exceeded its 50-day Moving Average on March 03, 2025
3/4/2025 - Tickeron - Stocks
Notable Two Hundred Day Moving Average Cross - BHC
3/3/2025 - Market News Video
Carl Icahn Stock Portfolio: Top 10 Stock Picks
2/28/2025 - Insider Monkey
Is Bausch Health Companies Inc. (BHC) the Best Low Price Pharma Stock to Invest In Right Now?
2/27/2025 - Insider Monkey
Bausch Health Companies (BHC, $7.54) price moved above its 50-day Moving Average on February 25, 2025
2/26/2025 - Tickeron - Stocks
Bausch Health Companies (NYSE:BHC) Shares Up 6.5% - What's Next?
2/25/2025 - MarketBeat
Bausch Health Companies Inc. (BHC) J.P. Morgan Global Leveraged Finance Conference Transcript
2/24/2025 - Seeking Alpha: Transcripts
Bausch Health Companies Inc. (BHC) J.P. Morgan Global Leveraged Finance Conference Transcript
2/24/2025 - SeekingAlpha
Van ECK Associates Corp Sells 119,848 Shares of Bausch Health Companies Inc. (NYSE:BHC)
2/22/2025 - MarketBeat
Bausch Health Companies (NYSE:BHC) Shares Gap Up - Still a Buy?
2/21/2025 - MarketBeat
Bausch Health Companies (TSE:BHC) Stock Price Up 7.4% - Here's Why
2/21/2025 - MarketBeat
Bausch Health Companies (BHC, $7.18) Moving Average Convergence Divergence (MACD) Histogram turned positive on February 20, 2025
2/21/2025 - Tickeron - Technical Analysis
Why Bausch Health Companies Inc. (BHC) Went Up On Thursday?
2/21/2025 - Insider Monkey
Bausch Health Companies (NYSE:BHC) Releases Quarterly Earnings Results, Misses Expectations By $0.44 EPS
2/20/2025 - MarketBeat
Bausch Health Companies (NYSE:BHC) Announces Quarterly Earnings Results
2/20/2025 - MarketBeat
Bausch Health Beats on Q4 Earnings and Revenues, Xifaxan Boosts Sales
2/20/2025 - Zacks Investment Research
Bausch Health Companies (NYSE:BHC) Shares Gap Up - What's Next?
2/20/2025 - Ticker Report
Q4 2024 Bausch Health Companies Inc Earnings Call Transcript
2/20/2025 - GuruFocus
Bausch Health Companies (BHC, $6.51) RSI Indicator left the oversold zone on February 19, 2025
2/20/2025 - Tickeron - Stocks
Bausch Health Companies (BHC) Expected to Announce Quarterly Earnings on Thursday
2/20/2025 - MarketBeat
Bausch Health Companies Inc. (BHC) Q4 2024 Earnings Call Transcript
2/20/2025 - Seeking Alpha: Transcripts
Income Statement
Total Revenue (TTM)
$9.63B
EBITDA (TTM)
$3.13B
EBIT (TTM)
$1.86B
Net Income (TTM)
-$46.00M
Balance Sheet
Total Assets (Q)
$26.52B
Total Debt (Q)
$21.84B
Total Liabilities (Q)
$26.85B
Book Value Per Share (Q)
-$3.48
Cash Flow
Cash from Operations (TTM)
$1.60B
Cash from Investing (TTM)
-$454.00M
Cash from Financing (TTM)
-$868.00M
Net Change in Cash (TTM)
$239.00M
Filings
Filing Date
Thursday, February 20, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of May (est)
Price History
Loading...
Beta
1.37
7-Day Total Return
-2.63%
30-Day Total Return
-3.15%
60-Day Total Return
0.19%
90-Day Total Return
-5.45%
Year to Date Total Return
-5.87%
1-Year Total Return
-13.72%
2-Year Total Return
-9.82%
3-Year Total Return
-61.40%
5-Year Total Return
-56.97%
52-week Low
Jul 24, 2024 - $5.45
52-week High
Apr 03, 2024 - $15.43
Valuation
Market Cap
$2.63B - Mid Cap
Enterprise Value
$24.25B
Price/Sales (TTM)
0.40
Price/Book (Q)
-2.95
Dividends and Shares
Shares Outstanding
372.00M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.bauschhealth.com
Phone Number
514 744 6792
Address
2150 St. ElzEar Boulevard West
Laval, QC H7L 4A8
Country
Canada
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology... more
Weiss Ratings